ArticleJournal of clinical laboratory analysis2026
The Genetic Link Between Primary Immune Thrombocytopenia and Depression/Anxiety Disorders: A Two-Sample Mendelian Randomization Study.
Article in Journal of clinical laboratory analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundPrimary immune thrombocytopenia (ITP) is an autoimmune bleeding disorder with complex immunopathogenesis. Its major symptoms, such as bleeding tendency and fatigue, may predispose patients to depression and anxiety. Although psychiatric comorbidities are increasingly recognized in ITP management, whether ITP causally contributes to these conditions remains unclear.
methodsWe conducted a two-sample Mendelian randomization (MR) study to investigate the potential genetically causal links between ITP and depression/anxiety. To ensure robustness, complementary MR approaches were performed, including pleiotropy-robust methods (MR-Corr and MRMix), multivariable MR adjusting for inflammatory biomarkers (C-reactive protein and interleukin-6), the robust adjusted profile score (RAPS) model, reverse MR, and colocalization analysis.
resultsMR analysis revealed a positive causal effect of ITP on depression (OR = 1.007, 95% CI: 1.001-1.013; p = 0.014), whereas no genetic predisposition of ITP on anxiety was observed. Multivariable and pleiotropy-robust sensitivity analyses supported the stability and consistency of the ITP-depression association, indicating that the result was unlikely driven by pleiotropy, instrument weakness, or inflammatory confounding.
conclusionThese findings provided novel genetic evidence supporting ITP-associated mental health issues and highlighted the importance of integrated psycho-hematological interventions for ITP in clinical practice. Future research was needed to elucidate the biological underpinning between ITP and psychiatric disorders, which might provide more options for ITP patients to improve life quality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.